Chemed (NYSE:CHE) Shares Down 3.8% – What’s Next?
by Tristan Rich · The Markets DailyChemed Corporation (NYSE:CHE – Get Free Report)’s share price dropped 3.8% during mid-day trading on Thursday . The company traded as low as $427.85 and last traded at $436.2860. Approximately 45,218 shares were traded during mid-day trading, a decline of 67% from the average daily volume of 136,003 shares. The stock had previously closed at $453.53.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on CHE shares. Royal Bank Of Canada reduced their price target on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research note on Monday, November 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, October 8th. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Chemed currently has a consensus rating of “Moderate Buy” and an average price target of $555.50.
Read Our Latest Report on Chemed
Chemed Trading Down 1.9%
The firm has a market cap of $6.30 billion, a price-to-earnings ratio of 23.53, a P/E/G ratio of 2.19 and a beta of 0.44. The business’s 50-day simple moving average is $436.21 and its two-hundred day simple moving average is $443.61.
Chemed (NYSE:CHE – Get Free Report) last posted its quarterly earnings data on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing the consensus estimate of $5.39 by ($0.12). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The firm had revenue of $624.90 million for the quarter, compared to analyst estimates of $626.04 million. During the same quarter last year, the company earned $5.64 earnings per share. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, analysts forecast that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.
Chemed Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Monday, November 17th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, November 17th. Chemed’s payout ratio is currently 12.69%.
Insider Activity at Chemed
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the completion of the sale, the chief executive officer owned 94,197 shares of the company’s stock, valued at $41,215,897.35. This trade represents a 2.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 3.29% of the stock is currently owned by insiders.
Institutional Trading of Chemed
Several large investors have recently modified their holdings of CHE. Geneos Wealth Management Inc. boosted its stake in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after acquiring an additional 76 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Chemed by 59.7% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 2,389 shares of the company’s stock valued at $1,130,000 after purchasing an additional 893 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in shares of Chemed by 148.0% during the second quarter. Farther Finance Advisors LLC now owns 372 shares of the company’s stock valued at $181,000 after purchasing an additional 222 shares during the period. Fortune Financial Advisors LLC boosted its position in shares of Chemed by 47.7% during the 2nd quarter. Fortune Financial Advisors LLC now owns 1,603 shares of the company’s stock worth $781,000 after purchasing an additional 518 shares in the last quarter. Finally, MBE Wealth Management LLC boosted its position in shares of Chemed by 9.0% during the 2nd quarter. MBE Wealth Management LLC now owns 592 shares of the company’s stock worth $288,000 after purchasing an additional 49 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.
About Chemed
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.